SAC Unit Will Pay $600M To Settle Insider Trading Claims

A unit of hedge fund SAC Capital Advisors LP has agreed to pay more than $600 million to resolve allegations that it traded on inside information about an experimental Alzheimer's drug,...

Already a subscriber? Click here to view full article